Inpatient Care - New Zealand | Statista Market Forecast

In New Zealand, the revenue in the Inpatient Care market is forecasted to reach NZD US$5.21bn by 2024.
The market is expected to exhibit a Compound Annual Growth Rate (CAGR 2024-2029) of 6.70%, leading to a market volume of NZD US$7.20bn by 2029.
When compared globally, United States is projected to generate the highest revenue in the Inpatient Care market, amounting to US$731.40bn in 2024.
New Zealand's inpatient care market is experiencing a surge in demand for specialized mental health services.

Definition:
Inpatient Care refers to medical and surgical services provided to patients who are admitted for overnight stays at hospitals. This market covers a wide range of services, such as diagnostics, medical treatments, and surgical treatments. It also includes facilities, nursing care, and other services that are necessary for the patient's recovery and well-being during their hospital stay. However, inpatient long-term care (LTC) for people with LTC needs is not included. Hospital inpatient care is a crucial component of the healthcare industry and is essential for providing high-quality and comprehensive medical care to patients.

Structure:
Inpatient Care covers Neoplasm Treatments, Treatments of Cardiovascular Diseases, Treatments of Musculoskeletal Diseases, Gastroenterology, Midwifery, and Other Inpatient Care. Other Inpatient Care provides information on additional areas that are not covered by the previously mentioned markets.

Additional information:
Inpatient Care comprises revenues, average revenue per capita, number of hospitals, average revenue per hospital, number of hospital beds, and average revenue per hospital bed. Market values represent revenues paid to hospitals by the respective healthcare payers (including VAT, if applicable). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Inpatient nursing care
Medical goods for inpatient treatments
Inpatient surgical treatments

Day care
Long-term care
Outpatient care
Home-based care

The Inpatient Care market in New Zealand has been experiencing steady growth in recent years.

Customer preferences: New Zealand has a universal healthcare system, which means that all residents have access to publicly funded healthcare services. Inpatient care is a crucial component of this system, and the majority of patients in New Zealand prefer to receive treatment in public hospitals. However, there is also a growing demand for private inpatient care, particularly among those who are willing to pay for shorter wait times and more personalized care.

Trends in the market: One of the main trends in the inpatient care market in New Zealand is the increasing use of technology to improve patient outcomes. This includes the use of electronic health records, telemedicine, and other digital tools to enhance communication and collaboration between healthcare providers. Another trend is the growing focus on preventative care and wellness, which is driving demand for services such as health screenings, vaccinations, and health education programs.

Local special circumstances: New Zealand has a relatively small population compared to other developed countries, which means that there are fewer healthcare providers and resources available. This can lead to longer wait times for certain types of inpatient care, particularly in rural areas. Additionally, there is a shortage of healthcare workers in New Zealand, which can make it difficult for hospitals and other healthcare facilities to provide high-quality care.

Underlying macroeconomic factors: The New Zealand government has been investing heavily in the healthcare sector in recent years, which has helped to drive growth in the inpatient care market. This includes funding for new hospitals and healthcare facilities, as well as initiatives to improve the quality of care and reduce wait times. Additionally, the aging population in New Zealand is driving demand for inpatient care services, as older adults are more likely to require hospitalization and other forms of medical treatment.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The healthcare landscape in the United States is a complicated one. There are federal health insurance plans for low-income individuals namely Medicaid and CHIP (Children’s health insurance program) and Medicare for seniors and the disabled. Aside from these, people must buy private health insurance or be left uninsured because the U.S. is the only high-income country without universal healthcare coverage. Hospitals in the U.S., therefore, receive payment from multiple payers. Most revenue generated by U.S. hospitals comes from private insurance, self, or other payments. The complexity of this multi-payer system is instrumental to the U.S. having the highest administrative health costs per capita among wealthy nations.